Cervical Cancer and Human Papillomavirus: Hearing Before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, Second Session, March 11, 2004
United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources
U.S. Government Printing Office, Jan 1, 2004 - Cervix uteri - 588 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
abnormal adolescents American Cancer Society anal cancer associated cells Centers for Disease cervical cancer screening chlamydia clinical Coburn colposcopy condom labeling condoms in preventing contraceptive Control and Prevention detection develop diagnosed Disease Control Drug Policy dysplasia effectiveness of condoms Epidemiology estimated evaluation family planning federal funding genital HPV infection genital warts gonorrhea high-risk HPV and cervical HPV DNA HPV prevention HPV testing HPV types HPV vaccine HPV-related human papillomavirus HPV human papillomavirus infection incidence infected with HPV intraepithelial invasive cervical cancer lesions million National Cancer Institute neoplasia Pap smear Pap test patients percent Policy and Human prevalence preventing HPV prevention of genital programs protect public health rates reduce the risk risk factors sex partners sexual activity sexual partners sexually transmitted diseases sexually transmitted infections SOUDER spermicide strategy studies Subcommittee on Criminal survey teens transmission treatment vaginal virus women